The creation of CARB-X was prioritized in the 2015 US National Action Plan on Combating Antibiotic-Resistant Bacteria (CARB), which called for a biopharmaceutical accelerator to spur pre-clinical product development.

The Founders of CARB-X Share Their Vision

Key Partners

Contact Information

765 Commonwealth Ave, Suite 1204
Boston, MA 02215

Register your email below to receive announcements about CARB-X:

Thanks for registering!